Sussex Partnership Nhs Foundation Trust Meeting
Total Page:16
File Type:pdf, Size:1020Kb
SUSSEX PARTNERSHIP NHS FOUNDATION TRUST MEETING OF THE BOARD OF DIRECTORS HELD IN PUBLIC 29 July 2015 10.30 – 12.40 Training Centre, Trust Headquarters, Swandean, Arundel Road, Worthing, West Sussex, BN13 3EP Contact: Rebecca Huth, Corporate Governance Administrator, [email protected], 01903 843033 BOARD OF DIRECTORS MEETING IN PUBLIC To be held on 29 July 2015 at 10.30 In the Training Centre, Swandean, Arundel Road, Worthing, West Sussex, BN13 3EP AGENDA TBP34 /15 INTRODUCTION 1030 TBP34 .1/15 Chair’s Welcome and Introduction Verbal 1030 TBP34 .2/15 Apologies for Absence & Declaration of Interests Verbal A Minutes of the Board of Directors meeting held 24 June 2015 & 1031 TBP34 .3/15 (to Action Points (not covered on the agenda) follow) 1032 TBP34 .4/15 Questions from Members of the Public Verbal TBP35 /15 STRATEGY To receive the Revalidation Report 1035 TBP35 .1/15 B (Tim Ojo, Executive Medical Director) To receive the Equality Performance Hub Annual Report 1040 TBP35 .2/15 C (Vincent Badu, Strategic Director of Social Care and Partnerships) To receive and agree the Medical Workforce Strategy 1045 TBP35 .3/15 D (Tim Ojo, Executive Medical Director) TBP36 /15 PERFORMANCE AND QUALITY E 1050 TBP36 .1/15 Chief Executive Report (to follow) To receive a report on the Performance of the Trust to the end of June 2015 1105 TBP36 .2/15 F (Sally Flint, Executive Director of Finance & Performance, Managing Directors) G 1135 TBP36 .3/15 To agree the Q1 in-year Governance Statement to Monitor (to (Peter Lee, Head of Corporate Governance) follow) To receive the Q1 Performance against Business Objectives 1140 TBP36 .4/15 H (Sally Flint, Executive Director of Finance and Performance) To receive a report on Learning from Serious Incidents 1145 TBP36 .5/15 I (Helen Greatorex, Executive Director of Nursing and Quality) To receive the Complaints Annual Report 1150 TBP36 .6/15 J (Helen Greatorex, Executive Director of Nursing and Quality) To receive the Sign Up to Safety Quarterly Report 1155 TBP36 .7/15 K (Helen Greatorex, Executive Director of Nursing and Quality) To receive an update on Safe Staffing 1200 TBP36 .8/15 L (Helen Greatorex, Executive Director of Nursing and Quality) TBP37 /15 GOVERNANCE Feedback from the Council meeting held on 27 July 2015 1205 TBP37 .1/15 Verbal (Caroline Armitage, Chair) To receive and agree the Board Assurance Framework 1210 TBP37 .2/15 M (Helen Greatorex, Executive Director of Nursing and Quality) To receive the Quarterly Notification of Sealed Documents 1215 TBP37 .3/15 N (Peter Lee, Head of Corporate Governance) TBP37 .4/15 To receive a report on the last meeting of the Finance and O Investment Committee (Richard Bayley, Non-Executive Director) TBP37 .5/15 To receive a report on the last meeting of the People Committee P (Diana Marsland, Non-Executive Director) 1220 TBP37 .6/15 To receive a report on the last meeting of the Audit Committee Q (Tim Masters, Non-Executive Director) To receive a report on the last meeting of the Charity Committee TBP37 .7/15 (Diana Marsland, Non-Executive Director) R 1235 TBP38 /15 ANY OTHER BUSINESS Date and Venue for Next Meeting: 30 September 2015 10.00– 12.30 Training Centre, Swandean, Arundel Road, Worthing, West Sussex, BN13 3EP To adopt the motion: “That representatives of the press and other members of the public be excluded from the remainder of this meeting, having regard to the confidential nature of the business to be transacted, publicity on which would be prejudicial to the public interest ” (Section 1(2) Public Bodies (Admission to Meetings) Act 1960) NB Those present at the meeting should be aware that their name will be issued in the notes of this meeting which may be released to members of the public on request Sussex Partnership NHS Foundation Trust Board of Directors 29th July 2015, Public Agenda Item: TBP35.1/15 Attachment: B For Discussion/Information By: Dr Tim Ojo Executive Medical Director IN CONFIDENCE 2014/2015 Medical Appraisal for Revalidation Annual Report SUMMARY & PURPOSE The Board of Directors is asked to note, discuss and seek any required clarification assurance about the implementation of ‘Medical Appraisal for Revalidation’ process within the Trust. This paper is a mandated requirement to provide an annual update to the Board within the context of the Framework of Quality Assurance for Responsible Officers and Revalidation published by NHS England in April 2014. LINK TO 20/20 vision The Strategic goals this paper relates to are: 1. Safe, effective, quality patient care. 4. Be the provider, employer and partner of choice ACTION REQUIRED BY BOARD The Board of Directors is also asked to approve the ‘Statement of Compliance’ confirming that Sussex Partnership NHS Foundation as a designated body is in compliance with the statutory regulations to be signed by the CE. 1.0 Executive Summary 1.1 Revalidation is the process by which the General Medical Council will confirm the continuation of a doctor’s license to practise in the UK. 1.2 Its purpose is to assure patients and the public, employers and other healthcare professionals that licensed doctors are up to date and fit to practise. 2.0 Introduction 2.1 The Medical Profession (Responsible Officers] Regulations 2010 (and as amended 2013 ) and GMC (License to Practice and Revalidation) Regulations 2012, set out the statutory responsibilities of Responsible Officers for each Designated body 2.2 Sussex Partnership NHS Foundation Trust is a ‘Designated body’ under these regulations and the Executive Medical Director is the Trust’s Responsible Officer. The Responsible Officer makes the recommendations to the GMC on behalf of the ‘Designated body.’ 2.3 Revalidation started on 3 December 2012 and it is anticipated that the majority of licensed doctors will by revalidated for the first time by 2016. 3.0 Report Requirements. 3.1 Revalidation recommendations are based on successful completion of: a) Annual medical appraisal (as set out in the Medical Appraisal Guide model form); b) At least one 360 degree (patient & colleague) feedback in a 5 year cycle. c) Royal College of Psychiatrists requirements such as evidence of participation in audit and case based discussion on an annual basis (the requirements are set out in College report 172). Revalidation is on a 5 year basis on the assumption that those revalidated will continue to fulfil their annual medical appraisal obligations over the said period. 3.2 The Responsible officer has three options available in making the revalidation recommendation: a) To recommend revalidation; b) To ask for a deferral; c) To inform the GMC of non-engagement in appraisal* * Non-engagement can potentially result in the GMC withdrawing a doctor’s license to practise through the administrative removal route. 3.3 The revalidation of trainee doctors is the statutory responsibility of the relevant Deaneries and their successor bodies such as HE-KSS. The Trust as a Local Education Provider plays a significant role in the process nevertheless. Performance Monitoring 3.4 In 2014/15 the Trust had a prescribed connection to 233 medical practitioners. 3.5 In 2014/15 the Trust made 90 positive revalidation recommendations and 11 deferrals to the GMC. (Please see appendix for breakdown of deferral reasons.) The number of recommendations was in keeping with GMC mandated scheduling which is as follows. 2013/14: 23% of doctors with a prescribed connection 2014/15: 40% of doctors with a prescribed connection 2015/16: 37% of doctors with a prescribed connection 3.6 In 2014/15 overall 80.6% of all doctors with a prescribed connection completed their annual appraisal with the prescribed timeframe. 3.7 Of the 46 doctors who had not completed their appraisals at the end of March 2015 all but 6 doctors have now completed their appraisals as at early July 2015. 3.8 Of these 6 doctors, 4 have now had the appraisal meeting and are awaiting sign-off, 1 is on long-term sick and 1 is about to have the appraisal meeting. Governance 3.10 The Trust as a Designated body is statutorily obliged to provide the Responsible Officer with the resources required to provide the appraisal and governance infrastructure to support Revalidation and oversee the following: a) Monitoring the frequency and quality of medical appraisals; b) Checking there are effective systems in place for monitoring the conduct and performance of doctors; c) Confirming that feedback from patients is sought to inform appraisal and revalidation; d) Ensuring appropriate pre-employment background checks are carried out. 3.11 The Responsible Officer has completed and submitted an Annual Organisational Audit (AQA) to NHS South (May 2015) in accordance with National guidance. 3.12 The Statement of Compliance is attached to this paper for Board information and agreement. (Appendix 1) 3.13 The Executive Medical Director is supported in the Responsible Officer role by the Deputy Medical Director (Workforce Governance), the Revalidation Support Administrator, and his Executive Assistant. 3.14 In line with the regulation the Trust has trained 40 enhanced appraisers who have been assigned a number of appraisees they are responsible for appraising over the next 2/3 years. We have also provided for alternate appraisers in the circumstances that the originally assigned appraiser is suddenly unable to undertake the function. Additionally 5 colleagues have undergone Case Investigator training who can now assist in the clinical performance assessment in the cases where remediation might be required. 3.15 The Trust has a Medical Appraisal for Revalidation Policy which has had Equality and Human Rights Impact Analysis with no areas of concerns identified. 3.16 There is a Revalidation Delivery Group that meets monthly to address any operational challenges in the delivery of Revalidation compliant annual appraisal for all doctors.